These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 6898414)
21. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly]. Blennow G; Fergusson A; Medvedeo A Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411 [TBL] [Abstract][Full Text] [Related]
22. A hypothesis concerning the difficulty of withdrawal from maintenance on methadone. Jackman JM Proc Natl Conf Methadone Treat; 1973; 1():471-5. PubMed ID: 4808187 [No Abstract] [Full Text] [Related]
23. Pharmacotherapeutic environments for substance use disorders. Gardner TJ; Kosten TR Am J Drug Alcohol Abuse; 2007; 33(5):627-9. PubMed ID: 17891655 [No Abstract] [Full Text] [Related]
24. [Pharmacological principles for the treatment of heroin abuse]. Oye I Tidsskr Nor Laegeforen; 1999 May; 119(14):2066-9. PubMed ID: 10394285 [No Abstract] [Full Text] [Related]
25. Techniques of withdrawal from methadone and their outcome over six months to two years. Chappel JN; Skolnick VB; Senay EC Proc Natl Conf Methadone Treat; 1973; 1():482-9. PubMed ID: 4808189 [No Abstract] [Full Text] [Related]
26. Methadone in maintenance treatment of narcotic addicts; joint revision of conditions for use; interim maintenance treatment; human immunodeficiency virus disease counseling--FDA and SAMHSA. Final rule. Fed Regist; 1993 Jan; 58(3):495-9. PubMed ID: 10171334 [TBL] [Abstract][Full Text] [Related]
28. Report of the Expert Advisory Committee on the Use of Drugs in the Treatment of Abuse and Dependence to Narcotic and Controlled Drugs. CMAJ; 1990 Nov; 143(9):861-5. PubMed ID: 2224712 [No Abstract] [Full Text] [Related]
29. Low efficacy of non-opioid drugs in opioid withdrawal symptoms. Hermann D; Klages E; Welzel H; Mann K; Croissant B Addict Biol; 2005 Jun; 10(2):165-9. PubMed ID: 16191669 [TBL] [Abstract][Full Text] [Related]
30. The role of the federal government in the development of narcotic antagonists. Green AI Adv Biochem Psychopharmacol; 1973; 8(0):576-7. PubMed ID: 4795123 [No Abstract] [Full Text] [Related]
31. Opiate-ethanol interactions: implications for the biological basis and treatment of combined addictive diseases. Kreek MJ NIDA Res Monogr; 1988; 81():428-39. PubMed ID: 3136382 [No Abstract] [Full Text] [Related]
32. Clinical treatment of opioid addiction and dependence. Ling W; Rawson RA; Compton M Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332 [No Abstract] [Full Text] [Related]
33. Opioid dependence: rationale for and efficacy of existing and new treatments. Fiellin DA; Friedland GH; Gourevitch MN Clin Infect Dis; 2006 Dec; 43 Suppl 4():S173-7. PubMed ID: 17109303 [TBL] [Abstract][Full Text] [Related]
34. Treatment options for opiate addiction. J Ky Med Assoc; 2004 May; 102(5):221-4. PubMed ID: 15152448 [No Abstract] [Full Text] [Related]
35. Infants born to narcotic-addicted mothers. Householder J; Hatcher R; Burns W; Chasnoff I Psychol Bull; 1982 Sep; 92(2):453-68. PubMed ID: 7146236 [No Abstract] [Full Text] [Related]
36. Heroin prescription in Europe: heroin treatment is a pragmatic way of reducing the risks associated with addiction. Prescrire Int; 2003 Dec; 12(68):235-6. PubMed ID: 14986702 [No Abstract] [Full Text] [Related]
37. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600 [TBL] [Abstract][Full Text] [Related]